Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-031189

President & CEO sold 13,383 shares at $31.37 ($419,825)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBIN HOWARD W President & CEO 2019-05-16 Sale −13,383 $31.37 $419,825 295,326 D: show line 1 in the form
Open-market sales · 13,383 sh · avg $31.37 · $419,825
Loading xslF345X03/doc4.xml…